Spinal Muscular Atrophy

werdnig hoffman disease wiki

Background

The spinal muscular atrophies (SMAs) comprise a group of autosomal-recessive disorders characterized by progressive weakness of the lower motor neurons.

In the early 1980s, Werdnig and Hoffman described a disorder of progressive muscular weakness beginning in infancy that resulted in early death, though the age of death was variable. In pathologic terms, the disease was characterized by loss of anterior horn cells. The central role of lower motor neuron degeneration was confirmed in subsequent pathologic studies demonstrating a loss of anterior horn cells in the spinal cord and cranial nerve nuclei. [1 ]

Since then, several types of spinal muscular atrophies have been described based on age when accompanying clinical features appear. The most common types are acute infantile (SMA type I, or Werdnig-Hoffman disease), chronic infantile (SMA type II), chronic juvenile (SMA type III or Kugelberg-Welander disease), and adult onset (SMA type IV) forms.

The genetic defects associated with SMA types I-III are localized on chromosome 5q11.2-13.3. [2. 3. 4. 5 ]

Many classification systems have been proposed and include variants based on inheritance, clinical, and genetic criteria. Among these are the Emery [6 ]. Pearn [7 ]. and International SMA Consortium system [8 ]. The ISMAC system is most widely accepted and is used in this review.

Katirji B, Kaminski HJ, Preston DC. Spinal muscular atrophies. Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE, eds. Neuromuscular Disorders in Clinical Practice. Boston: Butterworth-Heinemann; 2002. 445-53.

Bradley

WG, Daroff RB, Fenichel GM, Jankovic J, eds. Neurology in Clinical Practice. 2nd ed. Boston: Butterworth-Heinemann; 1996. 1829-43.

Brzustowicz LM, Lehner T, Castilla LH, et al. Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature. 1990 Apr 5. 344(6266):540-1. [Medline].

Harding AE, Thomas PK. Hereditary distal spinal muscular atrophy. A report on 34 cases and a review of the literature. J Neurol Sci. 1980 Mar. 45(2-3):337-48. [Medline].

Burlet P, Burglen L, Clermont O, et al. Large scale deletions of the 5q13 region are specific to Werdnig- Hoffmann disease. J Med Genet. 1996 Apr. 33(4):281-3. [Medline].

Emery AE. The nosology of the spinal muscular atrophies. J Med Genet. 1971 Dec. 8(4):481-95. [Medline].

Pearn J. Classification of spinal muscular atrophies. Lancet. 1980 Apr 26. 1(8174):919-22. [Medline].

Munsat TL, Davies KE. International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). Neuromuscul Disord. 1992. 2(5-6):423-8. [Medline].

Burglen L, Lefebvre S, Clermont O, et al. Structure and organization of the human survival motor neurone (SMN) gene. Genomicx. 1996. 32:479-482.

Lunn MR, Wang CH. Spinal muscular atrophy. Lancet. 2008 Jun 21. 371(9630):2120-33. [Medline].

Harding AE. Inherited neuronal atrophy and degeneration predominantly of lower motor neurons. Dyck PJ, Thomas PK, eds. Peripheral Neuropathy. 3rd ed. Philadelphia: WB Saunders; 1993. 1051-64.

Ogino S, Leonard DG, Rennert H, Ewens WJ, Wilson RB. Genetic risk assessment in carrier testing for spinal muscular atrophy. Am J Med Genet. 2002 Jul 15. 110(4):301-7. [Medline].

Awater C, Zerres K, Rudnik-Sch

Category: Disease

Similar articles: